These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 2011576)

  • 1. The Ca2(+)-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells.
    Funk SE; Sage EH
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2648-52. PubMed ID: 2011576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of endothelial cell proliferation by SPARC is mediated through a Ca(2+)-binding EF-hand sequence.
    Sage EH; Bassuk JA; Yost JC; Folkman MJ; Lane TF
    J Cell Biochem; 1995 Jan; 57(1):127-40. PubMed ID: 7721952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of SPARC and cationic SPARC peptides on DNA synthesis by endothelial cells and fibroblasts.
    Funk SE; Sage EH
    J Cell Physiol; 1993 Jan; 154(1):53-63. PubMed ID: 8419407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells.
    Hasselaar P; Sage EH
    J Cell Biochem; 1992 Jul; 49(3):272-83. PubMed ID: 1644864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of endothelial cell shape by SPARC does not involve chelation of extracellular Ca2+ and Mg2+.
    Sage EH
    Biochem Cell Biol; 1992 Jan; 70(1):56-62. PubMed ID: 1581032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPARC, a secreted protein associated with cellular proliferation, inhibits cell spreading in vitro and exhibits Ca+2-dependent binding to the extracellular matrix.
    Sage H; Vernon RB; Funk SE; Everitt EA; Angello J
    J Cell Biol; 1989 Jul; 109(1):341-56. PubMed ID: 2745554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of gene expression by SPARC during angiogenesis in vitro. Changes in fibronectin, thrombospondin-1, and plasminogen activator inhibitor-1.
    Lane TF; Iruela-Arispe ML; Sage EH
    J Biol Chem; 1992 Aug; 267(23):16736-45. PubMed ID: 1379603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretion of SPARC by endothelial cells transformed by polyoma middle T oncogene inhibits the growth of normal endothelial cells in vitro.
    Sage EH
    Biochem Cell Biol; 1992 Jul; 70(7):579-92. PubMed ID: 1449724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of PDGF-stimulated and matrix-mediated proliferation of human vascular smooth muscle cells by SPARC is independent of changes in cell shape or cyclin-dependent kinase inhibitors.
    Motamed K; Funk SE; Koyama H; Ross R; Raines EW; Sage EH
    J Cell Biochem; 2002; 84(4):759-71. PubMed ID: 11835401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroblastoma angiogenesis is inhibited with a folded synthetic molecule corresponding to the epidermal growth factor-like module of the follistatin domain of SPARC.
    Chlenski A; Liu S; Baker LJ; Yang Q; Tian Y; Salwen HR; Cohn SL
    Cancer Res; 2004 Oct; 64(20):7420-5. PubMed ID: 15492265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional mapping of SPARC: peptides from two distinct Ca+(+)-binding sites modulate cell shape.
    Lane TF; Sage EH
    J Cell Biol; 1990 Dec; 111(6 Pt 2):3065-76. PubMed ID: 2269665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPARC mediates focal adhesion disassembly in endothelial cells through a follistatin-like region and the Ca(2+)-binding EF-hand.
    Murphy-Ullrich JE; Lane TF; Pallero MA; Sage EH
    J Cell Biochem; 1995 Feb; 57(2):341-50. PubMed ID: 7539008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression.
    Gupta SK; Singh JP
    J Cell Biol; 1994 Nov; 127(4):1121-7. PubMed ID: 7962072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cleavage of the matricellular protein SPARC by matrix metalloproteinase 3 produces polypeptides that influence angiogenesis.
    Sage EH; Reed M; Funk SE; Truong T; Steadele M; Puolakkainen P; Maurice DH; Bassuk JA
    J Biol Chem; 2003 Sep; 278(39):37849-57. PubMed ID: 12867428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPARC (secreted protein acidic and rich in cysteine) regulates endothelial cell shape and barrier function.
    Goldblum SE; Ding X; Funk SE; Sage EH
    Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3448-52. PubMed ID: 8159767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of insulin-like growth factor I receptor-dependent expression of p107 and cyclin A in cells that lack the extracellular matrix protein secreted protein acidic and rich in cysteine.
    Basu A; Rodeck U; Prendergast GC; Howe CC
    Cell Growth Differ; 1999 Nov; 10(11):721-8. PubMed ID: 10593648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of sulfasalazine on bovine endothelial cell proliferation and cell cycle phase distribution. Comparison with olsalazine, 5-aminosalicylic acid, and sulfapyridine.
    Sharon P; Drab EA; Linder JS; Weidman SW; Sabesin SM; Rubin DB
    J Lab Clin Med; 1992 Jan; 119(1):99-107. PubMed ID: 1345796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific interaction of SPARC with endothelial cells is mediated through a carboxyl-terminal sequence containing a calcium-binding EF hand.
    Yost JC; Sage EH
    J Biol Chem; 1993 Dec; 268(34):25790-6. PubMed ID: 8245016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of extracellular proteins is correlated with angiogenesis in vitro.
    Iruela-Arispe ML; Hasselaar P; Sage H
    Lab Invest; 1991 Feb; 64(2):174-86. PubMed ID: 1705300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification of biologically active SPARC expressed in Saccharomyces cerevisiae.
    Yost JC; Bell A; Seale R; Sage EH
    Arch Biochem Biophys; 1994 Oct; 314(1):50-63. PubMed ID: 7944407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.